CN Patent

CN103533927A — 用于生理学活性成分经皮给药的组合物

Assigned to Novartis AG · Expires 2014-01-22 · 12y expired

What this patent protects

本发明公开了用于生理学活性成分(例如药物或兽药成分)经皮给药的组合物。所述组合物特征在于能够形成非粘性、非常柔韧的薄膜，它具有极佳的长期疗效。

USPTO Abstract

本发明公开了用于生理学活性成分(例如药物或兽药成分)经皮给药的组合物。所述组合物特征在于能够形成非粘性、非常柔韧的薄膜，它具有极佳的长期疗效。

Drugs covered by this patent

Patent Metadata

Patent number
CN103533927A
Jurisdiction
CN
Classification
—
Expires
2014-01-22
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.